XML 53 R40.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation (Tables)
9 Months Ended
Mar. 31, 2026
Share-Based Compensation  
Schedule of Components of Share-Based Compensation Expenses in the Condensed Consolidated Statements of Operations and Comprehensive Loss

The following table summarizes the components of share-based compensation expense in the condensed consolidated statements of operations and comprehensive loss (in thousands):

  ​ ​ ​

Three Months Ended

Nine Months Ended

March 31, 

March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

2026

  ​ ​ ​

2025

Research and development

$

38

$

14

$

72

$

37

General and administrative

 

339

 

356

 

881

 

1,223

Total

$

377

$

370

$

953

$

1,260

Schedule of Stock Option Issuances During Period

Issuances of stock options during the nine months ended March 31, 2026 were as follows:

Grantee

Plan

# of Options

Exercise Price

Vesting

Term

Employee

2023 Plan

423,000

$1.83 - $2.15

25% 1st year and quarterly thereafter

10 years

Directors

2023 Plan

81,000

$1.00

Monthly over one year

10 years

Executive Officers

 

2023 Plan

 

310,000

 

$0.893

 

25% 1st year and quarterly thereafter

 

10 years

Executive Officers

 

2023 Plan

 

804,000

 

$2.23

 

25% 1st year and quarterly thereafter

 

10 years

Total

1,618,000

Schedule of Black-Scholes Option Pricing Model Assumptions Used in Determining Fair Value of Stock Options Granted

Weighted-average risk-free interest rate

3.64% - 3.94

%  

Dividend yield

 

0

%  

Volatility

 

229.25% - 233.93

%  

Expected term (in years)

 

5.7 - 6.3